Fate Therapeutics Appoints Chris M. Storgard, M.D. as Chief Medical Officer
17 mai 2016 08h01 HE
|
Fate Therapeutics, Inc.
SAN DIEGO, May 17, 2016 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ:FATE), a biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for cancer and...